MGRX
MANGOCEUTICALS (MGRX)
NASDAQ
$0.33-$0.01 (-4.03%)
Price as of Jun 23, 2026 7:59 PM EDT
  • $5.0M
    Market Cap
  • -84.35%
    1-Year Change
  • Health Information Services
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
456,021
-25.96%
615,873
-15.81%
731,493
N/A
Cost of Revenue
54,422
-41.67%
93,296
-39.77%
154,900
N/A
Gross Profit
250,386
-34.10%
379,964
-11.94%
431,501
N/A
Sales and Marketing Expense
822,860
-44.35%
1.5M
-29.50%
2.1M
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
1.1M
+11,198.70%
9,936
-60.08%
24,889
N/A
Total Operating Expenses
18.3M
+118.90%
8.4M
-13.45%
9.7M
N/A
Operating Profit
-18.0M
+126.20%
-8.0M
-13.53%
-9.2M
N/A
Interest Income
N/A
N/A
N/A
N/A
6,473
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
-100.00%
6,473
N/A
Total Nonoperating Income and Expense
-2.6M
+255.14%
-735,233
-11,458.46%
6,473
N/A
Income before Taxes
-20.6M
+137.08%
-8.7M
-5.48%
-9.2M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
0
N/A
0
N/A
0
N/A
Net Income
-20.6M
+137.11%
-8.7M
-5.50%
-9.2M
N/A
Net Income from Continuing Operations Applicable to Common
-21.8M
+150.58%
-8.7M
-5.48%
-9.2M
N/A
Basic EPS and Net Income
-2.17
-55.17%
-4.84
+749.12%
-0.57
N/A
Diluted EPS and Net Income
-2.17
-55.17%
-4.84
+749.12%
-0.57
N/A
Basic Weighted Average Shares
10.1M
+408.93%
2.0M
-87.72%
16.1M
N/A
Diluted Weighted Average Shares
10.1M
+408.93%
2.0M
-87.72%
16.1M
N/A
Balance Sheet
Cash and Cash Equivalents
1.5M
+2,434.12%
58,653
-92.06%
739,006
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.5M
+2,434.12%
58,653
-92.06%
739,006
N/A
Total Current Assets
1.5M
+1,947.01%
75,595
-90.76%
818,460
N/A
Accumulated Depreciation
1,012
-55.14%
2,256
-92.15%
28,752
N/A
Property and Plant and Equipment and Net
1,794
-36.07%
2,806
-97.08%
96,129
N/A
Total Long-Term Assets
14.5M
-4.92%
15.3M
+11,129.42%
136,204
N/A
Total Assets
16.1M
+4.68%
15.4M
+1,362.75%
1.1M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
500,000
+233.33%
150,000
N/A
N/A
N/A
Total Current Liabilities
890,568
-37.52%
1.4M
+575.33%
211,078
N/A
Total Long-Term Debt
75,000
-25.00%
100,000
+166.67%
37,500
N/A
Total Long-Term Liabilities
75,005
-97.55%
3.1M
+4,611.67%
64,961
N/A
Total Liabilities
890,568
-37.52%
1.4M
+416.40%
276,039
N/A
Retained Earnings
-40.6M
+95.36%
-20.8M
+85.31%
-11.2M
N/A
Total Stockholders Equity
15.2M
+8.99%
13.9M
+1,700.07%
774,754
N/A
Total Shares Outstanding
15.9M
+389.54%
3.2M
-84.85%
21.4M
N/A
Cash Flow
Cash from Operating Activities
-5.9M
+20.28%
-4.9M
-30.49%
-7.0M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
3,519
N/A
Cash from Investing Activities
N/A
N/A
65,000
+1,947.12%
-3,519
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
7.3M
+76.12%
4.1M
-41.50%
7.1M
N/A
Financials Ratio
Gross Margin
88.07%
+3.79%
84.85%
N/A
N/A
N/A
Operating Margin
-3,954.28%
+205.49%
-1,294.42%
N/A
N/A
N/A
Return on Assets
-131.23%
+23.76%
-106.03%
N/A
N/A
N/A
Return on Equity
-141.65%
+19.75%
-118.28%
N/A
N/A
N/A
Revenue Growth
-25.96%
+64.21%
-15.81%
N/A
N/A
N/A
Current Ratio
1.74
+3,178.49%
0.05
N/A
N/A
N/A
Cash Ratio
1.67
+3,960.83%
0.04
N/A
N/A
N/A
Debt-to-Equity Ratio
0.04
+111.17%
0.02
N/A
N/A
N/A
Debt-to-Assets Ratio
0.04
+119.02%
0.02
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow